Also trades as: NOVO-B.CO (CPH) · $vol 179M · NOV.DE (XETRA) · $vol 8M · NOVC.DE (XETRA) · $vol 5M · NONOF (OTC) · $vol 3M · NOVO.TO (TSX) · $vol 0M
NVO NYSE
Novo Nordisk A/S
1W: -3.9%
1M: -20.2%
3M: -24.3%
YTD: -28.8%
1Y: -37.0%
3Y: -58.2%
5Y: -22.3%
$37.32
-0.08 (-0.21%)
Weekly Expected Move ±5.0%
$34
$35
$37
$39
$41
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$119.1B
-1.5% ▼
5Y CAGR: +18.0%
Capital Expenditures
$90.1B
-75.6% ▼
5Y CAGR: +32.5%
Free Cash Flow
$29.0B
-58.4% ▼
5Y CAGR: -0.6%
Dividends Paid
$49.8B
-12.8% ▼
Buybacks
$1.3B
+93.4% ▲
Net Change in Cash
$10.8B
+755.8% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $47.8B | $55.5B | $83.7B | $101.0B | $102.4B |
| Depreciation & Amort. | $6.0B | $7.4B | $9.4B | $8.5B | $14.7B |
| Stock-Based Comp. | $1.0B | $1.5B | $2.1B | $2.3B | $0 |
| Change in Working Capital | -$8.7B | -$5.5B | -$12.2B | -$12.0B | $3.7B |
| Other Non-Cash Items | -$2.5B | $6.5B | $4.9B | -$5.1B | -$1.7B |
| Operating Cash Flow | $55.0B | $78.9B | $108.9B | $121.0B | $119.1B |
| — Investing Activities — | |||||
| Capital Expenditures | -$7.4B | -$12.1B | -$25.8B | -$47.2B | -$60.1B |
| Acquisitions (Net) | -$18.3B | -$7.1B | $0 | -$82.2B | $1.0B |
| Investment Purchases | -$7.1B | -$9.7B | -$13.3B | -$19.8B | -$723M |
| Investment Sales | $1.2B | $6.6B | $8.3B | $24.4B | $10.7B |
| Other Investing | $4M | -$2.6B | -$13.1B | -$4.1B | -$30.0B |
| Investing Cash Flow | -$31.6B | -$24.9B | -$43.9B | -$128.9B | -$79.2B |
| — Financing Activities — | |||||
| Net Debt Issuance | $15.5B | -$2.4B | -$1.5B | $73.1B | $24.7B |
| Stock Repurchased | -$19.4B | -$24.1B | -$29.9B | -$20.2B | -$1.3B |
| Dividends Paid | -$21.5B | -$25.3B | -$31.8B | -$44.1B | -$49.8B |
| Other Financing | $0 | $0 | $0 | $0 | -$2.0B |
| Financing Cash Flow | -$25.5B | -$51.8B | -$63.2B | $8.7B | -$28.4B |
| Net Change in Cash | -$1.5B | $1.9B | $1.7B | $1.3B | $10.8B |
| Cash End of Period | $10.7B | $12.7B | $14.4B | $15.7B | $26.5B |
| Free Cash Flow | $47.6B | $64.1B | $70.0B | $69.7B | $29.0B |